NR4A1 and breast cancer: In this paper, we have used a Test Cancer BioChip that contains siRNA for breast cancer targets and controls and determined their effects on anchorage-independent growth of hormone receptor positive (MCF7) and HER2 positive (SK-BR-3) breast cancer cell lines.